| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |